TESARO Inc. is an oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients.


Updates from The Motley Fool

Latest updates on Tesaro from Fool.com.  The Fool has written over 100 articles on Tesaro.


Stock Performance

View Interactive TSRO Charts
Sponsored by

Key Data Points

Primary metrics and data points about Tesaro.
Current Price: $150.04
Prev Close: $153.19
Open: $152.84
Bid: $150.51
Ask: $150.71
Day's Range: $148.58 - $156.22
52wk Range: $36.71 - $192.94
Volume: 351,822
Avg Vol 810,740
Market Cap: $8B
P/E (ttm): -19.64
EPS (ttm): ($7.80)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Tesaro.
CAPS Rating 2 out of 5
 
44 Outperform
18 Underperform
CAPS All Stars
 
17 Outperform
11 Underperform

How do you think Tesaro will perform against the market?



You pick for Tesaro is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Lonnie Moulder, CEO

100% Approve

Based on 10 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Tesaro.

TESARO Inc. is an oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers